You are currently viewing a new version of our website. To view the old version click .

1,738 Results Found

  • Article
  • Open Access
10 Citations
3,380 Views
14 Pages

Allogeneic Bone-Marrow Mesenchymal Stem Cell with Moldable Cryogel for Craniofacial Bone Regeneration

  • Cheng-Feng Chu,
  • Shih-Hsuan Mao,
  • Victor Bong-Hang Shyu,
  • Chih-Hao Chen and
  • Chien-Tzung Chen

7 December 2021

Allogeneic bone-marrow mesenchymal stem cells (BMSCs) can promote bone regeneration and substitute for autologous BMSCs if autologous sources are unavailable, but the efficacy of bone regeneration by allogeneic BMSCs is still inconsistent. A Lewis ra...

  • Review
  • Open Access
57 Citations
18,571 Views
25 Pages

12 January 2024

This last decade, chimeric antigen receptor (CAR) T-cell therapy has become a real treatment option for patients with B-cell malignancies, while multiple efforts are being made to extend this therapy to other malignancies and broader patient populati...

  • Review
  • Open Access
87 Citations
7,466 Views
14 Pages

Systematic Review: Allogenic Use of Stromal Vascular Fraction (SVF) and Decellularized Extracellular Matrices (ECM) as Advanced Therapy Medicinal Products (ATMP) in Tissue Regeneration

  • Pietro Gentile,
  • Aris Sterodimas,
  • Jacopo Pizzicannella,
  • Laura Dionisi,
  • Domenico De Fazio,
  • Claudio Calabrese and
  • Simone Garcovich

Stromal vascular fraction (SVF) containing adipose stem cells (ASCs) has been used for many years in regenerative plastic surgery for autologous applications, without any focus on their potential allogenic role. Allogenic SVF transplants could be bas...

  • Article
  • Open Access
18 Citations
4,376 Views
13 Pages

Autologous Mesenchymal Stroma Cells Are Superior to Allogeneic Ones in Bone Defect Regeneration

  • Anna E. Rapp,
  • Ronny Bindl,
  • Annika Erbacher,
  • Anne Kruchen,
  • Markus Rojewski,
  • Hubert Schrezenmeier,
  • Ingo Müller and
  • Anita Ignatius

The application of autologous mesenchymal stem cells (MSC) for the treatment of bone defects requires two invasive procedures and several weeks of ex vivo cell expansion. To overcome these limitations, the administration of allogeneic MSC may be attr...

  • Review
  • Open Access
80 Citations
8,304 Views
20 Pages

The Importance of HLA Assessment in “Off-the-Shelf” Allogeneic Mesenchymal Stem Cells Based-Therapies

  • Marta Kot,
  • Monika Baj-Krzyworzeka,
  • Rafał Szatanek,
  • Aleksandra Musiał-Wysocka,
  • Magdalena Suda-Szczurek and
  • Marcin Majka

13 November 2019

The need for more effective therapies of chronic and acute diseases has led to the attempts of developing more adequate and less invasive treatment methods. Regenerative medicine relies mainly on the therapeutic potential of stem cells. Mesenchymal s...

  • Review
  • Open Access
17 Citations
5,635 Views
15 Pages

Allogeneic Hematopoietic Stem Cell Transplantation in Cutaneous T-Cell Lymphomas

  • Maëlle Dumont,
  • Régis Peffault de Latour,
  • Caroline Ram-Wolff,
  • Martine Bagot and
  • Adèle de Masson

3 October 2020

Cutaneous T-cell lymphomas (CTCLs) are non-Hodgkin lymphomas that develop primarily in the skin. They account for almost 80% of primary cutaneous lymphomas. Epidermotropic CTCLs (mycosis fungoides (MF) and Sézary syndrome (SS)) are the most co...

  • Review
  • Open Access
3 Citations
3,399 Views
18 Pages

Allogeneic Stem Cell Transplantation in Refractory Acute Myeloid Leukaemia

  • Roberto Bono,
  • Giuseppe Sapienza,
  • Stefania Tringali,
  • Cristina Rotolo,
  • Caterina Patti,
  • Antonino Mulè,
  • Valeria Calafiore,
  • Alessandra Santoro and
  • Luca Castagna

26 April 2024

Refractory acute myeloid leukaemia is very difficult to treat and represents an unmet clinical need. In recent years, new drugs and combinations of drugs have been tested in this category, with encouraging results. However, all treated patients relap...

  • Review
  • Open Access
162 Citations
13,303 Views
25 Pages

3 June 2019

Natural killer (NK) cells are attractive within adoptive transfer settings in cancer immunotherapy due to their potential for allogeneic use; their alloreactivity is enhanced under conditions of killer immunoglobulin-like receptor (KIR) mismatch with...

  • Review
  • Open Access
13 Citations
4,733 Views
15 Pages

29 January 2021

Allogeneic hematopoietic cell transplantation (HCT) is the only potentially curative therapy for a variety of hematologic diseases. However, this therapeutic platform is limited by an initial period when patients are profoundly immunocompromised. The...

  • Brief Report
  • Open Access
15 Citations
2,755 Views
7 Pages

A Third Dose COVID-19 Vaccination in Allogeneic Hematopoietic Stem Cell Transplantation Patients

  • Marika Watanabe,
  • Kimikazu Yakushijin,
  • Yohei Funakoshi,
  • Goh Ohji,
  • Hiroya Ichikawa,
  • Hironori Sakai,
  • Wataru Hojo,
  • Miki Saeki,
  • Yuri Hirakawa and
  • Sakuya Matsumoto
  • + 12 authors

29 October 2022

We previously reported that a second dose of BNT162b2 was safe and effective for allogeneic hematopoietic stem cell transplantation (HSCT) patients. Here, we investigated the safety and efficacy of a third dose of COVID-19 mRNA vaccine in allogeneic...

  • Article
  • Open Access
1 Citations
1,443 Views
15 Pages

Exploring Outcomes by Ethnicity in Allogeneic Hematopoietic Cell Transplantation

  • Elizabeth Herrity,
  • Sanjay Singhabahu,
  • Mats Remberger,
  • Tommy Alfaro Moya,
  • Igor Novitzky Basso,
  • Ivan Pasic,
  • Wilson Lam,
  • Arjun D. Law,
  • Auro Viswabandya and
  • Armin Gerbitz
  • + 5 authors

14 February 2025

Background: Clinical outcome disparities among racial and ethnic groups have been described following allogeneic hematopoietic cell transplantation (HCT). This study investigated the impact of race and ethnicity on HCT outcomes in a multi-ethnic sing...

  • Review
  • Open Access
9 Citations
3,286 Views
20 Pages

The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting

  • Elisabetta Metafuni,
  • Luca Di Marino,
  • Sabrina Giammarco,
  • Silvia Bellesi,
  • Maria Assunta Limongiello,
  • Federica Sorà,
  • Filippo Frioni,
  • Roberto Maggi,
  • Patrizia Chiusolo and
  • Simona Sica

Microbiota changes during allogeneic hematopoietic stem cell transplantation has several known causes: conditioning chemotherapy and radiation, broad-spectrum antibiotic administration, modification in nutrition status and diet, and graft-versus-host...

  • Article
  • Open Access
3 Citations
3,954 Views
14 Pages

Due to their osteoconductive properties, allogenic bone screws made of human cortical bone have advantages regarding rehabilitation compared to other materials such as stainless steel or titanium. Since conventional screw drives like hexagonal or hex...

  • Review
  • Open Access
492 Views
36 Pages

15 December 2025

Chimeric antigen receptor (CAR)-T cell therapies represent a promising therapeutic approach for refractory autoimmune diseases. Although autologous CAR-T cells have achieved success thus far, they require expensive, individualised manufacturing, limi...

  • Article
  • Open Access
4 Citations
2,491 Views
33 Pages

Autologous and Allogeneic Cytotherapies for Large Knee (Osteo)Chondral Defects: Manufacturing Process Benchmarking and Parallel Functional Qualification

  • Virginie Philippe,
  • Annick Jeannerat,
  • Cédric Peneveyre,
  • Sandra Jaccoud,
  • Corinne Scaletta,
  • Nathalie Hirt-Burri,
  • Philippe Abdel-Sayed,
  • Wassim Raffoul,
  • Salim Darwiche and
  • Lee Ann Applegate
  • + 2 authors

Cytotherapies are often necessary for the management of symptomatic large knee (osteo)-chondral defects. While autologous chondrocyte implantation (ACI) has been clinically used for 30 years, allogeneic cells (clinical-grade FE002 primary chondroprog...

  • Case Report
  • Open Access
1 Citations
1 Views
2 Pages

Acute Abdomen After Allogenic Haematopoietic Stem Cell Transplantation

  • Alessandro Crocoli,
  • Daria Pagliara,
  • Franco Locatelli and
  • Alessandro Inserra

1 December 2011

We report a case of a patient underwent allogenic hematopoietic stem cell transplantation complicated by acute colonic pseudo obstruction who require surgery after failure of conservative therapy.

  • Case Report
  • Open Access
4 Citations
2 Pages

Pneumothorax in an Early Phase after Allogeneic Hematopoietic Stem Cell Transplantation

  • Yasuhiro Ebihara,
  • Shohei Yamamoto,
  • Shinji Mochizuki,
  • Masao Tsukada,
  • Yuki Taya,
  • Toshiro Kawakita,
  • Seiko Kato,
  • Jun Ooi,
  • Satoshi Takahashi and
  • Arinobu Tojo
  • + 1 author

Pneumothorax is very rare after early phase of hematopoietic stem cell transplantation (HSCT) and usually accompanied with pulmonary chronic graft-versus-host disease (GVHD), such as bronchiolitis obliterans and bronchiolitis obliterans organizing pn...

  • Article
  • Open Access
1 Citations
2,136 Views
7 Pages

Allogeneic Limbal Transplants Integrate into the Corneal Surface and Lead to an Improved Visual Acuity

  • Christiane Kesper,
  • Joana Heinzelmann,
  • Anja Viestenz,
  • Thomas Hammer,
  • Sabine Foja,
  • Marlene Stein and
  • Arne Viestenz

13 January 2023

Limbal stem cell deficiency (LSCD) severely impairs vision and can lead to blindness. LSCD causes include chemical burns, infections, multiple previous operations and congenital malformations. Allogeneic limbal transplantation is a procedure for trea...

  • Communication
  • Open Access
8 Citations
3,603 Views
12 Pages

Tolerogenic dendritic cells (tolDC) play a central role in regulating immune homeostasis and in promoting peripheral tolerance. These features render tolDC a promising tool for cell-based approaches aimed at inducing tolerance in T-cell mediated dise...

  • Article
  • Open Access
4 Citations
3,869 Views
13 Pages

Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

  • Donata Backhaus,
  • Madlen Jentzsch,
  • Lara Bischof,
  • Dominic Brauer,
  • Christina Wilhelm,
  • Julia Schulz,
  • Georg-Nikolaus Franke,
  • Wolfram Pönisch,
  • Vladan Vucinic and
  • Uwe Platzbecker
  • + 1 author

13 November 2021

Background: For most patients with acute myeloid leukemia (AML) harboring a trisomy 8 an allogeneic hematopoietic stem cell transplantation (HSCT) is a suitable and recommended consolidation therapy. However, comparative outcome analyses between pati...

  • Review
  • Open Access
101 Citations
13,266 Views
15 Pages

Recent Advances in Allogeneic CAR-T Cells

  • Dong Wook Kim and
  • Je-Yoel Cho

10 February 2020

In recent decades, great advances have been made in the field of tumor treatment. Especially, cell-based therapy targeting tumor associated antigen (TAA) has developed tremendously. T cells were engineered to have the ability to attack tumor cells by...

  • Review
  • Open Access
3,537 Views
9 Pages

The Role of Allogeneic Transplantation in Chronic Myeloid Leukemia in 2023: A Case-Based Concise Review

  • Mario Tiribelli,
  • Giuseppe Petruzzellis,
  • Giulia Battaglia,
  • Martina Pucillo,
  • Marta Lisa Battista,
  • Michela Cerno,
  • Antonella Geromin,
  • Gabriele Facchin,
  • Umberto Pizzano and
  • Daniela Damiani
  • + 2 authors

15 August 2023

Tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of chronic myeloid leukemia (CML), granting patients a life expectancy close to that of the normal population and, in a subset of patients, the possibility to discontinue therapy. No...

  • Review
  • Open Access
20 Citations
4,471 Views
9 Pages

Thrombocytopenia and Therapeutic Strategies after Allogeneic Hematopoietic Stem Cell Transplantation

  • Leyre Bento,
  • Mariana Canaro,
  • José María Bastida and
  • Antonia Sampol

2 March 2022

Thrombocytopenia following allogeneic hematopoietic stem cell transplantation is a usual complication and can lead to high morbidity and mortality. New strategies, such as the use of another graft versus host-disease prophylaxis, alternative donors,...

  • Article
  • Open Access
13 Citations
4,263 Views
19 Pages

Long-Term Outcome and Rejection After Allogeneic Uterus Transplantation in Cynomolgus Macaques

  • Iori Kisu,
  • Hirohito Ishigaki,
  • Katsura Emoto,
  • Yojiro Kato,
  • Yohei Yamada,
  • Kentaro Matsubara,
  • Hideaki Obara,
  • Yohei Masugi,
  • Yusuke Matoba and
  • Masataka Adachi
  • + 14 authors

1 October 2019

Uterus transplantation (UTx) is an option for women with uterine factor infertility to have a child, but is still in the experimental stage. Therefore, allogeneic animal models of UTx are required for resolution of clinical issues. In this study, lon...

  • Review
  • Open Access
6 Citations
4,816 Views
18 Pages

Bridging Strategies to Allogeneic Transplant for Older AML Patients

  • Judith Hecker,
  • Isabella Miller,
  • Katharina S. Götze and
  • Mareike Verbeek

11 July 2018

Treatment options for older patients with intermediate or high-risk acute myeloid leukemia (AML) remain unsatisfactory. Allogeneic stem cell transplantation, the treatment of choice for the majority of younger AML patients, has been hampered in elder...

  • Article
  • Open Access
3 Citations
2,001 Views
20 Pages

26 November 2023

Neutrophils display heterogeneity and plasticity with different subgroups and immune-regulatory functions under various surrounding conditions. Neutrophils induced by IL-23/IL-18 (referred to N(IL-23+IL-18) neutrophils) have a unique gene-expression...

  • Article
  • Open Access
3 Citations
819 Views
6 Pages

Economic Analysis of Allogeneic Hematopoietic Stem Cell Transplantation in the Bone Marrow Transplant Center of Tunisia

  • Leila Achour,
  • Chema Drira,
  • Mohamed Zied Sboui,
  • Ikram Fazaa,
  • Mohamed Ali Soussi,
  • Senda Hammami,
  • Tarek Ben Othman and
  • Myriam Razgallah Khrouf

Introduction: New procedures and diagnostic tests in hematopoietic stem cell transplantation (HSCT) are associated with a significant increase in costs. The last cost estimate of allogeneic HSCT done in Tunisia was in 1996 and concerned only direct m...

  • Review
  • Open Access
22 Citations
8,980 Views
13 Pages

The Current Status of Allogenic Islet Cell Transplantation

  • Zofia Czarnecka,
  • Nidheesh Dadheech,
  • Haide Razavy,
  • Rena Pawlick and
  • A. M. James Shapiro

10 October 2023

Type 1 Diabetes (T1D) is an autoimmune destruction of pancreatic beta cells. The development of the Edmonton Protocol for islet transplantation in 2000 revolutionized T1D treatment and offered a glimpse at a cure for the disease. In 2022, the 20-year...

  • Review
  • Open Access
23 Citations
3,992 Views
17 Pages

Allogeneic Dentin Graft: A Review on Its Osteoinductivity and Antigenicity

  • In-Woong Um,
  • Jeong-Keun Lee,
  • Jun-Young Kim,
  • Yu-Mi Kim,
  • Neema Bakhshalian,
  • Yeong Kon Jeong and
  • Jeong-Kui Ku

31 March 2021

Studies on allogeneic demineralized dentin matrix (Allo-DDM) implantation in the 1960s and 1970s provided the most reliable preclinical evidence of bone formation and antigenicity in an extraosseous site. Recently, applications of Allo-DDM at skeleta...

  • Review
  • Open Access
24 Citations
6,382 Views
15 Pages

19 October 2018

Coronary heart disease is the leading cause of death worldwide with huge socio-economic consequences. Cell therapy, and particularly mesenchymal stem cells (MSC), are considered a promising option to treat this disorder, due to their robust trophic a...

  • Article
  • Open Access
35 Citations
6,579 Views
17 Pages

Due to their multifactorial aspects, mesenchymal stem cells (MSCs) have been widely established as an attractive and potential candidate for the treatment of a multitude of diseases. A substantial number of studies advocate that MSCs are poorly immun...

  • Article
  • Open Access
10 Citations
3,971 Views
9 Pages

The Application of an Allogenic Bone Screw for Stabilization of a Modified Chevron Osteotomy: A Prospective Analysis

  • Thorsten Huber,
  • Stefan G. Hofstätter,
  • Rainer Fiala,
  • Florian Hartenbach,
  • Robert Breuer and
  • Björn Rath

3 March 2022

Background: Distal first metatarsal osteotomies are commonly performed operative procedures for hallux valgus deformity, and usually involve fixation with a metal screw. However, various bioabsorbable osteosynthesis materials have been in use for a n...

  • Review
  • Open Access
1,863 Views
18 Pages

Allogeneic NKG2D CAR-T Cell Therapy: A Promising Approach for Treating Solid Tumors

  • Sabir A. Mukhametshin,
  • Elvina M. Gilyazova,
  • Damir R. Davletshin,
  • Irina A. Ganeeva,
  • Ekaterina A. Zmievskaya,
  • Vitaly V. Chasov,
  • Alexsei V. Petukhov,
  • Aigul Kh. Valiullina,
  • Sheila Spada and
  • Emil R. Bulatov

22 September 2025

Chimeric Antigen Receptor (CAR)-T cell therapy has transformed the treatment landscape of cancer, yet major challenges remain in enhancing efficacy, reducing adverse effects, and expanding accessibility. Autologous CAR-T cells, derived from individua...

  • Review
  • Open Access
34 Citations
6,081 Views
29 Pages

The Role of Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Leukemia

  • Mattia Algeri,
  • Pietro Merli,
  • Franco Locatelli and
  • Daria Pagliara

25 August 2021

Allogeneic hematopoietic stem cell transplantation (HSCT) offers potentially curative treatment for many children with high-risk or relapsed acute leukemia (AL), thanks to the combination of intense preparative radio/chemotherapy and the graft-versus...

  • Review
  • Open Access
8 Citations
2,291 Views
13 Pages

Searching for the Optimal Donor for Allogenic Adipose-Derived Stem Cells: A Comprehensive Review

  • Tihomir Georgiev-Hristov,
  • Mariano García-Arranz,
  • Jacobo Trébol-López,
  • Paula Barba-Recreo and
  • Damián García-Olmo

Adipose-derived stem cells comprise several clinically beneficial qualities that have been explored in basic research and have motivated several clinical studies with promising results. After being approved in the European Union, UK, Switzerland, Isr...

  • Article
  • Open Access
1 Citations
3 Pages

Allogeneic Stem Cell Transplantation in Acute Myeloid Leukemia

  • Natasha Ali,
  • Salman Naseem Adil,
  • Mohammad Usman Shaikh and
  • Nehal Masood

29 November 2012

We report a case series of 12 patients with acute myeloid leukemia who underwent allogeneic stem cell transplant with a matched related donor. Male to female ratio was 1:1. The main complication post-transplant was graft-versus-host disease (n = 7 pa...

  • Article
  • Open Access
28 Citations
4,213 Views
10 Pages

HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation

  • Malte Roerden,
  • Annika Nelde,
  • Jonas S. Heitmann,
  • Reinhild Klein,
  • Hans-Georg Rammensee,
  • Wolfgang A. Bethge and
  • Juliane S. Walz

8 July 2020

The diversity of human leukocyte antigens (HLAs) enables the presentation of immense repertoires of peptides, including tumor-associated antigens (TAAs). As a surrogate for immunopeptidome diversity, the HLA evolutionary divergence (HED) between indi...

  • Case Report
  • Open Access
3 Citations
1,028 Views
3 Pages

5 March 2021

Capillary leak syndrome (CLS) is a severe complication of allogeneic hematopoietic stem cell transplantation (HSCT) characterized by weight gain, generalized edema, hypotension, and hypoalbuminemia. The primary pathogenesis is injury of the capillary...

  • Interesting Images
  • Open Access
465 Views
8 Pages

Early Radiological Limitations in Bone Healing Estimation After Allogeneic Bone Grafts Used for Mandible Reconstruction

  • Kamil Nelke,
  • Klaudiusz Łuczak,
  • Maciej Janeczek,
  • Mikołaj Włodarczyk,
  • Magdalena Florek,
  • Małgorzata Tarnowska,
  • Agata Małyszek,
  • Cyprian Olchowy,
  • Maciej Dobrzyński and
  • Piotr Kuropka

27 October 2025

Xenograft bone, autologous bone grafts or allogeneic bones from a bone bank are used for bone augmentation, reconstruction or other purposes, when the volume, shape, and size of each jawbone defect require different bone materials. In the case of som...

  • Article
  • Open Access
14 Citations
4,017 Views
15 Pages

HLA-DPB1 Reactive T Cell Receptors for Adoptive Immunotherapy in Allogeneic Stem Cell Transplantation

  • Sebastian Klobuch,
  • Kathrin Hammon,
  • Sarah Vatter-Leising,
  • Elisabeth Neidlinger,
  • Michael Zwerger,
  • Annika Wandel,
  • Laura Maria Neuber,
  • Bernhard Heilmeier,
  • Regina Fichtner and
  • Carina Mirbeth
  • + 2 authors

20 May 2020

HLA-DPB1 antigens are mismatched in about 80% of allogeneic hematopoietic stem cell transplantations from HLA 10/10 matched unrelated donors and were shown to be associated with a decreased risk of leukemia relapse. We recently developed a reliable i...

  • Review
  • Open Access
13 Citations
4,185 Views
11 Pages

6 June 2021

The intestinal barrier consists of an epithelial lining covered with specialized mucus inhabited by intestinal microbiota. An intact gut barrier ensures a resistance to bacteria and toxins translocation. On the other hand, gut permeability allows the...

  • Review
  • Open Access
6 Citations
5,154 Views
24 Pages

Pros and Cons of Cryopreserving Allogeneic Stem Cell Products

  • Caterina Giovanna Valentini,
  • Claudio Pellegrino and
  • Luciana Teofili

21 March 2024

The COVID-19 pandemic has precipitously changed the practice of transplanting fresh allografts. The safety measures adopted during the pandemic prompted the near-universal graft cryopreservation. However, the influence of cryopreserving allogeneic gr...

  • Article
  • Open Access
3 Citations
3,928 Views
10 Pages

Use of an Intramedullary Allogenic Fibular Strut Bone and Lateral Locking Plate for Distal Femoral Fracture with Supracondylar Comminution in Patients over 50 Years of Age

  • Wen-Chin Su,
  • Tzai-Chiu Yu,
  • Cheng-Huan Peng,
  • Kuan-Lin Liu,
  • Wen-Tien Wu,
  • Ing-Ho Chen,
  • Jen-Hung Wang and
  • Kuang-Ting Yeh

20 December 2022

Background and Objectives: Distal femoral fracture is a severe injury that makes surgery challenging, particularly comminuted fractures in the supracondylar region. This study aimed to evaluate the outcomes of distal femoral fracture treated with the...

  • Article
  • Open Access
23 Citations
6,440 Views
21 Pages

Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients

  • Jing Zhu,
  • Tejendra Patel,
  • Jordan A. Miller,
  • Chad D. Torrice,
  • Mehak Aggarwal,
  • Margaret R. Sketch,
  • Maurice D. Alexander,
  • Paul M. Armistead,
  • James M. Coghill and
  • Tatjana Grgic
  • + 14 authors

Tacrolimus exhibits high inter-patient pharmacokinetics (PK) variability, as well as a narrow therapeutic index, and therefore requires therapeutic drug monitoring. Germline mutations in cytochrome P450 isoforms 4 and 5 genes (CYP3A4/5) and the ATP-b...

  • Review
  • Open Access
24 Citations
5,108 Views
21 Pages

Allogeneic Stem Cell Transplantation in Mantle Cell Lymphoma in the Era of New Drugs and CAR-T Cell Therapy

  • Miriam Marangon,
  • Carlo Visco,
  • Anna Maria Barbui,
  • Annalisa Chiappella,
  • Alberto Fabbri,
  • Simone Ferrero,
  • Sara Galimberti,
  • Stefano Luminari,
  • Gerardo Musuraca and
  • Alessandro Re
  • + 2 authors

14 January 2021

MCL is an uncommon lymphoproliferative disorder that has been regarded as incurable since its identification as a distinct entity. Allogeneic transplantation for two decades has represented the only option capable of ensuring prolonged remissions and...

  • Article
  • Open Access
643 Views
14 Pages

Allogeneic Umbilical Cord Blood Serum Eyedrops for the Treatment of Severe Dry Eye Disease Patients

  • Marco Zeppieri,
  • Giuseppe Gagliano,
  • Matteo Capobianco,
  • Caterina Gagliano,
  • Francesco Cappellani,
  • Giuseppa Tancredi,
  • Alessandro Avitabile,
  • Ludovica Cannizzaro and
  • Fabiana D’Esposito

6 November 2025

Human allogeneic umbilical cord blood serum stands out as a potent adjunct to conventional therapies for ocular surface disorders related to severe Dry Eye Disease. By expediting ocular surface regeneration and fostering epithelial integrity, umbilic...

  • Article
  • Open Access
18 Citations
3,672 Views
21 Pages

20 December 2022

Purpose: the aim of this study was to identify potential risk factors favoring complications by assessing the number and types of complications associated with allogeneic or autogenous bone blocks applied as onlay grafts for alveolar ridge augmentati...

  • Review
  • Open Access
3 Citations
3,987 Views
28 Pages

15 July 2022

Rationale: Allogeneic hematopoietic stem cell transplantation (HSCT) is associated with increased treatment-related mortality, loss of physical vitality, and impaired quality of life. Future research will investigate the effects of multidisciplinary...

  • Article
  • Open Access
9 Citations
3,117 Views
18 Pages

Clinical Proof-of-Concept of a Non-Gene Editing Technology Using miRNA-Based shRNA to Engineer Allogeneic CAR T-Cells

  • Caroline Lonez,
  • Jennifer Bolsée,
  • Fanny Huberty,
  • Thuy Nguyen,
  • Céline Jacques-Hespel,
  • Sebastien Anguille,
  • Anne Flament and
  • Eytan Breman

15 February 2025

With the success of chimeric antigen receptor (CAR) T-cell therapy in B-cell malignancies, efforts are being made to extend this therapy to other malignancies and broader patient populations. However, limitations associated with the time-consuming an...

  • Article
  • Open Access
1 Citations
1,841 Views
15 Pages

Overall Survival Rate in Allogeneic Stem Cell Transplanted Patients Requiring Intensive Care Can Be Predicted by the Prognostic Index for Critically Ill Allogeneic Transplantation Patients (PICAT) and the Sequential Organ Failure Assessment (SOFA) Scores

  • Adrien De Voeght,
  • Evelyne Willems,
  • Sophie Servais,
  • Laurence Seidel,
  • Michelle Pirotte,
  • Paul Massion,
  • Nathalie Layios,
  • Maguy Pereira,
  • Benoit Misset and
  • Jean-Luc Canivet
  • + 2 authors

31 August 2022

Background. Allogeneic hematopoietic stem cell transplantation (allo-HCT) recipients requiring intensive care unit (ICU) have high mortality rates. Methods. In the current study, we retrospectively assessed whether the Prognostic Index for Critically...

of 35